Hal Gibson

Hal Gibson brings 22 years of sales, marketing, and business development experience in transplant diagnostics. Prior to CareDx, Hal was at One Lambda, Inc. where he was a leader in launching and driving early clinical research and commercial adoption of single antigen bead technology for detection of Anti-HLA donor specific antibodies. Post-acquisition of One Lambda by Thermo Fisher Diagnostics, he served as a senior leader in their Transplant Diagnostics business where he helped drive clinical strategy and business development. Hal received a Bachelor of Science in Biology from the University of Tampa.